The Cavalier King Charles Spaniel was rebuilt from a handful of dogs in the late 1920s. The breed's founding bottleneck created a gene pool that was narrow from day one and narrowed further through popular sire effects. The two conditions that define the Cavalier's health profile — mitral valve disease and syringomyelia — are deeply embedded in that genetics. Understanding how they're inherited is essential for anyone considering this breed.
Mitral Valve Disease: Polygenic Inheritance
The mitral valve separates the left atrium from the left ventricle. In MVD, the valve leaflets degenerate, allowing blood to leak backward with each heartbeat. The heart enlarges to compensate, and eventually the compensation fails. The endpoint is congestive heart failure.
MVD in Cavaliers is polygenic — controlled by multiple genes, each contributing a portion of the risk. No single mutation to test for, no simple inheritance pattern. Genome-wide association studies have identified significant regions on chromosomes CFA13 and CFA14 (Madsen et al., Journal of Veterinary Internal Medicine, 2011), with subsequent work identifying additional associations on CFA15 (containing FSTL5) and CFA2 (containing ARHGAP26). Candidate genes including HEPACAM2, CDK6, and FAH — all related to the TGF-beta pathway involved in heart development — have emerged from runs-of-homozygosity analysis. The nebulette locus has also been associated with disease severity (Meurs et al., 2022). Despite these advances, no commercially reliable DNA test for MVD risk exists, and the full genetic architecture remains incompletely mapped.
Because no DNA test predicts MVD reliably, the primary strategy is phenotypic selection — breeding only from dogs that remain murmur-free beyond specified ages. Protocols recommending both parents clear at 2.5 years or older, with grandparents documented clear at later ages, have demonstrated measurable results: offspring develop MVD later on average. The disease doesn't disappear, but onset shifts later — buying years of healthy life.
Syringomyelia and Chiari-like Malformation
Chiari-like malformation (CM) occurs when the skull's caudal fossa is too small for the cerebellum, forcing brain tissue through the foramen magnum and obstructing cerebrospinal fluid flow. Fluid-filled cavities called syrinxes form within the spinal cord, causing pain, neurological deficits, and the characteristic "phantom scratching" that never makes skin contact.
Like MVD, CM/SM inheritance is polygenic — multiple genes controlling craniofacial development contribute. The condition exists on a spectrum: many Cavaliers show CM on MRI without developing symptomatic syringomyelia. Others develop severe, painful syrinxes requiring medical management.
MRI is the only reliable screening tool. Grading schemes evaluate cerebellar herniation and syrinx presence. The cost is substantial, limiting adoption, but breeders who MRI screen are gradually reducing severe presentations in the breeding population.
Testable Single-Gene Conditions
Two breed-specific conditions follow straightforward inheritance and are reliably DNA-testable:
- Episodic Falling Syndrome (EFS): BCAN gene mutation. Autosomal recessive. Causes exercise-triggered stiffness and collapse.
- Curly Coat/Dry Eye Syndrome (CC/DE): FAM83H gene mutation. Autosomal recessive. Produces rough coat texture and severely dry eyes.
Both tests are inexpensive and widely available. The Cavalier puppy health screening checklist covers what documentation to verify.
The Practical Takeaway
Health testing can shift MVD onset later, reduce severe CM/SM in breeding stock, and eliminate EFS and CC/DE entirely. It cannot guarantee any individual dog will be unaffected or replace the genetic diversity the breed has lost. The Cavalier King Charles Spaniel breed guide covers how these realities shape the ownership decision.
Frequently Asked Questions
Can I DNA-test a Cavalier King Charles Spaniel for MVD risk?
Not reliably with current commercial tests. MVD is polygenic — multiple genes contribute, and the specific loci are still being mapped. No commercially available DNA test can predict whether an individual Cavalier will develop MVD or when. Cardiac auscultation and echocardiography remain the primary screening tools, and multi-generational phenotypic data from the breeding line is the most informative predictor available.
Is syringomyelia painful for every affected Cavalier?
No. Syringomyelia exists on a spectrum. Some dogs show significant Chiari-like malformation on MRI but never develop clinical signs. Others develop painful syrinxes that require ongoing pain management. The severity depends on the extent of cerebellar herniation, the size and location of syrinxes, and individual variation in pain perception and neurological response. MRI findings do not always correlate directly with clinical severity.
Are Cavalier King Charles Spaniels getting healthier through breeding programs?
Progress is measurable but gradual. Breeding programs that consistently select for later MVD onset have demonstrated that the age at which murmurs first appear can be shifted later in successive generations. MRI screening is reducing the proportion of severely CM/SM-affected dogs entering breeding programs. DNA testing has made EFS and CC/DE manageable. The breed is moving in the right direction. But the genetic burden accumulated over decades of narrow breeding does not reverse quickly, and the pace of improvement depends on widespread adoption of health protocols — which remains uneven across the global Cavalier breeding community.